Search Results - Scott J. Rodig

Refine Results
  1. 1
    Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

    Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma by Reid W. Merryman, Philippe Armand, Kyle Wright, Scott J. Rodig

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The biology and treatment of EML4-ALK non-small cell lung cancer

    The biology and treatment of EML4-ALK non-small cell lung cancer by Takaaki Sasaki, Scott J. Rodig, Lucian R. Chirieac, Pasi A. Jänne

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia

    MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia by Richard Byers, Treeve Currie, Eleni Tholouli, Scott J. Rodig, Jeffery L. Kutok

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth

    ADAM12 Transmembrane and Secreted Isoforms Promote Breast Tumor Growth by Roopali Roy, Scott J. Rodig, Diane R. Bielenberg, David Zurakowski, Marsha A. Moses

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration

    Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration by Michael Kluk, Kieran P. Ryan, Bonnie Wang, Guoqi Zhang, Scott J. Rodig, Teresa Sánchez

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth <i>In Vitro</i> and <i>In Vivo</i>

    Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth <i>In Vitro</i> and <i>In Vivo</i> by Yansheng Hao, Bjoern Chapuy, Stefano Monti, Heather H. Sun, Scott J. Rodig, Margaret A. Shipp

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas

    ROS1 Immunohistochemistry for Detection of ROS1-Rearranged Lung Adenocarcinomas by Lynette M. Sholl, Heather H. Sun, Mohit Butaney, Chengsheng Zhang, Charles Lee, Pasi A. Jänne, Scott J. Rodig

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging

    Diffuse large B-cell lymphomas have spatially defined, tumor immune microenvironments revealed by high-parameter imaging by Kyle Wright, Jason L. Weirather, Sizun Jiang, Katrina Kao, Yari Sigal, Anita Giobbie‐Hurder, Margaret A. Shipp, Scott J. Rodig

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

    Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy by Michael R. Green, Scott J. Rodig, Przemysław Juszczyński, Jing Ouyang, Papiya Sinha, Evan A. O’Donnell, Donna Neuberg, Margaret A. Shipp

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features

    AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features by Scott J. Rodig, Jing Ouyang, Przemysław Juszczyński, Treeve Currie, Kenneth Law, Donna Neuberg, Gabriel A. Rabinovich, Margaret A. Shipp, Jeffery L. Kutok

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

    Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis by Catriona Jamieson, Robert P. Hasserjian, Jason Gotlib, Jorge E. Cortés, Richard M. Stone, Moshe Talpaz, Jürgen Thiele, Scott J. Rodig, Olga Pozdnyakova

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice

    MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice by Michael Kluk, Caleb Ho, Hongbo Yu, Benjamin J. Chen, Donna Neuberg, Paola Dal Cin, Bruce A. Woda, Geraldine S. Pinkus, Scott J. Rodig

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

    VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma by Xinqi Wu, Anita Giobbie‐Hurder, Xiaoyun Liao, Donald P. Lawrence, David F. McDermott, Jun Zhou, Scott J. Rodig, F. Stephen Hodi

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas

    Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas by Michael Kluk, Bjoern Chapuy, Papiya Sinha, Alyssa Roy, Paola Dal Cin, Donna Neuberg, Stefano Monti, Geraldine S. Pinkus, Margaret A. Shipp, Scott J. Rodig

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4- positive T-cells that are PD-1-negative

    The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4- positive T-cells that are PD-1-negative by Sanjay S. Patel, Jason L. Weirather, Mikel Lipschitz, Ana Lako, Pei-Hsuan Chen, Gabriel K. Griffin, Philippe Armand, Margaret A. Shipp, Scott J. Rodig

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Nodular primary cutaneous melanoma is associated with PD-L1 expression

    Nodular primary cutaneous melanoma is associated with PD-L1 expression by Mara Giavina‐Bianchi, Pedro Giavina‐Bianchi, Mirian Nacagamo Sotto, Scott J. Rodig, Martín C. Mihm, Cyro Festa Neto, Lyn M. Duncan, Jorge Kalil

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Lipocalin 2 promotes breast cancer progression

    Lipocalin 2 promotes breast cancer progression by Jiang Yang, Diane R. Bielenberg, Scott J. Rodig, Robert Doiron, Matthew C. Clifton, Andrew L. Kung, Roland K. Strong, David Zurakowski, Marsha A. Moses

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

    The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma by Przemysław Juszczyński, Jing Ouyang, Stefano Monti, Scott J. Rodig, Kunihiko Takeyama, Jeremy S. Abramson, Wen Chen, Jeffery L. Kutok, Gabriel A. Rabinovich, Margaret A. Shipp

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain

    Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain by Min Shi, Margaretha G.M. Roemer, Bjoern Chapuy, Xiaoyun Liao, Heather H. Sun, Geraldine S. Pinkus, Margaret A. Shipp, Gordon J. Freeman, Scott J. Rodig

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis

    Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis by Laura Lovato, Simon N. Willis, Scott J. Rodig, Tyler Caron, Stefany Almendinger, Owain W. Howell, Richard Reynolds, Kevin C. O’Connor, David A. Hafler

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: